Abbott Laboratories is expected to file its next quarterly report (Form 10-Q), for the period ending about Sept. 30, 2026, between Oct. 28, 2026 and Nov. 2, 2026, based on its last 8 10-Q filings. The SEC deadline for a large accelerated filer is Nov. 9, 2026.
How the next-report window is calculated
Abbott Laboratories's most recent periodic report on file is a Form 10-Q for the period ended June 30, 2026, filed July 28, 2026. Its fiscal year ends around Dec. 31, so the next period should close about Sept. 30, 2026, and that report is a Form 10-Q.
SEC rules give a large accelerated filer 40 days after period end to file a 10-Q, which lands on Nov. 9, 2026 after moving off weekends and federal holidays. Over its last 8 10-Qs, Abbott Laboratories filed between 28 and 32 days after period end (median 30 days), which gives the expected window above. Period ends are estimated from the company's own calendar and may shift by a few days in 52/53-week fiscal years.
Recent filings by Abbott Laboratories
| Filed | Form | What it is | Document |
|---|---|---|---|
| 8-K | Information shared under Regulation FD; other events the company chose to report | Open 8-K filed 2026-08-20 · Index 0001104659-26-099247 | |
| 10-Q | Quarterly report with unaudited financial statements for the period ended June 30, 2026 | Open 10-Q filed 2026-07-28 · Index 0001628280-26-050134 | |
| 8-K | Released earnings or financial results | Open 8-K filed 2026-07-16 · Index 0001628280-26-048377 | |
| 11-K | Annual report of an employee stock purchase or savings plan | Open 11-K filed 2026-06-18 · Index 0001104659-26-075724 | |
| SD | Specialized disclosure (conflict minerals / resource payments) | Open SD filed 2026-05-27 · Index 0001104659-26-066986 | |
| 13G | Ownership above 5% by a passive or institutional investor | Open SCHEDULE 13G filed 2026-04-29 · Index 0002100119-26-000151 | |
| 10-Q | Quarterly report with unaudited financial statements for the period ended March 31, 2026 | Open 10-Q filed 2026-04-29 · Index 0001628280-26-028357 | |
| 8-K | Executive or board change, or executive pay arrangement; changed its charter, bylaws or fiscal year; reported shareholder vote results | Open 8-K filed 2026-04-27 · Index 0001104659-26-049434 | |
| S-8 | Registration of shares for employee benefit plans | Open S-8 filed 2026-04-24 · Index 0001104659-26-048560 | |
| 8-K | Other events the company chose to report | Open 8-K filed 2026-04-17 · Index 0001104659-26-044892 | |
| 8-K | Released earnings or financial results | Open 8-K filed 2026-04-16 · Index 0001628280-26-025365 | |
| 13G/A | Amendment to a passive-ownership (13G) report | Open SCHEDULE 13G/A filed 2026-03-26 · Index 0000102909-26-000500 | |
| S-8 | Registration of shares for employee benefit plans | Open S-8 filed 2026-03-23 · Index 0001104659-26-033413 | |
| 8-K | Other events the company chose to report | Open 8-K filed 2026-03-23 · Index 0001104659-26-033079 | |
| ARS | Annual report delivered to shareholders | Open ARS filed 2026-03-13 · Index 0001308179-26-000066 | |
| DEFA14A | Additional proxy soliciting materials | Open DEFA14A filed 2026-03-13 · Index 0001308179-26-000065 | |
| DEF 14A | Definitive proxy statement for a shareholder meeting | Open DEF 14A filed 2026-03-13 · Index 0001308179-26-000064 | |
| 8-K | Signed a material contract; took on new debt or a similar obligation | Open 8-K filed 2026-03-09 · Index 0001104659-26-025240 | |
| 8-K | Signed a material contract | Open 8-K filed 2026-02-26 · Index 0001104659-26-020509 | |
| S-3ASR | Automatic shelf registration (well-known seasoned issuer) | Open S-3ASR filed 2026-02-23 · Index 0001104659-26-018381 | |
| 8-K | Changed its charter, bylaws or fiscal year | Open 8-K filed 2026-02-20 · Index 0001104659-26-018167 | |
| 10-K | Annual report with audited financial statements for the period ended Dec. 31, 2025 | Open 10-K filed 2026-02-20 · Index 0001628280-26-010185 | |
| 8-K | Released earnings or financial results | Open 8-K filed 2026-01-22 · Index 0001628280-26-002982 | |
| 8-K | Executive or board change, or executive pay arrangement; changed its charter, bylaws or fiscal year | Open 8-K filed 2025-12-12 · Index 0001104659-25-120657 | |
| 13G/A | Amendment to a passive-ownership (13G) report | Open SCHEDULE 13G/A filed 2025-12-03 · Index 0000102909-25-000355 |
What Abbott Laboratories's 8-Ks were about in the past year
Abbott Laboratories filed 13 Form 8-K current reports between Oct. 17, 2025 and Oct. 16, 2026. Each report lists the item numbers it covers; the counts below show how often each item appeared.
| Item | Meaning | Times |
|---|---|---|
| 9.01 | Financial Statements and Exhibits | 13 |
| 8.01 | Other Events | 4 |
| 2.02 | Results of Operations and Financial Condition | 3 |
| 5.03 | Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 3 |
| 1.01 | Entry into a Material Definitive Agreement | 3 |
| 7.01 | Regulation FD Disclosure | 2 |
| 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 2 |
| 5.07 | Submission of Matters to a Vote of Security Holders | 1 |
| 2.03 | Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement | 1 |
| 5.04 | Temporary Suspension of Trading Under Registrant's Employee Benefit Plans | 1 |